Tricaprilin-d50
Product Specifications
UNSPSC Description
Tricaprilin-d50 is the deuterium labeled Tricaprilin. Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].
Target Antigen
Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease;Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C(OC([2H])([2H])C(OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)([2H])C([2H])([2H])OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]
Molecular Weight
520.99
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Kwok MK, et al. Re-thinking Alzheimer's disease therapeutic targets using gene-based tests. EBioMedicine. 2018 Nov;37:461-470.|[3]Tricaprylin
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6137757-01 0.1 mL
MYLK2 (Myosin Light Chain Kinase 2 Skeletal/Cardiac Muscle, MLCK2, MLCK, Myosin Light Chain Kinase 2, skMLCK, KMLC) APC
Ask
View Details MBS6137757-02 5x 0.1 mL
MYLK2 (Myosin Light Chain Kinase 2 Skeletal/Cardiac Muscle, MLCK2, MLCK, Myosin Light Chain Kinase 2, skMLCK, KMLC) APC
Ask
View Details